Skip to main content
Veterinary Medicines

Salmoporc lyophilisate and solvent for suspension for injection for pigs

Authorised
  • Salmonella enterica, subsp. enterica, serovar Typhimurium, strain 421/125 (histidine-adenine auxotrohic), Live

Product identification

Medicine name:
Salmoporc, lyophilisate and solvent for suspension for injection for pigs
Salmoporc lyophilisate and solvent for suspension for injection for pigs
Active substance:
  • Salmonella enterica, subsp. enterica, serovar Typhimurium, strain 421/125 (histidine-adenine auxotrohic), Live
Target species:
  • Pig
Route of administration:
  • Oral use
  • Subcutaneous use

Product details

Active substance and strength:
  • Salmonella enterica, subsp. enterica, serovar Typhimurium, strain 421/125 (histidine-adenine auxotrohic), Live
    8.00
    log10 colony forming unit(s)
    /
    1.00
    millilitre(s)
Pharmaceutical form:
  • Lyophilisate for suspension for injection
Withdrawal period by route of administration:
  • Oral use
    • Pig
      • Meat and offal
        6
        week
  • Subcutaneous use
    • Pig
      • Meat and offal
        6
        week
Anatomical therapeutic chemical veterinary (ATCvet) codes:
  • QI09AE02
Authorisation status:
  • Valid
Authorised in:
  • Ireland
Package description:
  • Cardboard box containing 1 vial with 20 doses (1 dose = 1 ml) lyophilised vaccine
  • 1 vial with 20 ml solvent

Additional information

Entitlement type:
  • Marketing Authorisation
Marketing authorisation holder:
  • Ceva Sante Animale
Marketing authorisation date:
Manufacturing sites for batch release:
  • Ceva-Phylaxia Zrt.
  • IDT Biologika GmbH
Responsible authority:
  • Health Products Regulatory Authority
Authorisation number:
  • VPA10815/064/001
Date of authorisation status change:
Reference member state:
  • Netherlands
Procedure number:
  • NL/V/0247/001
Concerned member states:
  • Austria
  • Belgium
  • Czechia
  • Denmark
  • Hungary
  • Ireland
  • Italy
  • Portugal
  • Romania
  • Slovakia
  • United Kingdom (Northern Ireland)
How useful was this page?:
No votes yet
"Please do not include any personal data, such as your name or contact details. If you do, you consent to the processing of that data in accordance with EMA’s Privacy Statement concerning requests for information or access to documents. If you would like a reply from EMA, please Send a question to EMA instead."